Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis

Documenti analoghi

• A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
  di: Couillard, S, et al.
  Pubblicazione: (2021)
• Asthma in pregnancy: An update
  di: Couillard, S, et al.
  Pubblicazione: (2020)
• Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
  di: Moran, AM, et al.
  Pubblicazione: (2020)
• Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
  di: Couillard, S, et al.
  Pubblicazione: (2020)
• Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
  di: Moran, A, et al.
  Pubblicazione: (2020)